MultivisionDx

MultivisionDx

Private
HelsinkiHealthcare & Life Scienceshttps://multivision.ai/

Last Round

Pre Seed

Dec 3, 2025

Total Funding Raised

$1.87M

Momentum Score

25 /100

Company Overview

MultivisionDx is a biotechnology company that builds AI-powered decision-support tools for personalized diagnosis and treatment selection for solid cancer.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Precision Medicine, Drug Discovery, Biotechnology

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Hardware Sales, Government Contracts

AI Layer

Application

Keywords

AI diagnosticscomputational pathologypersonalized cancer treatmentdigital pathologyspatial biologyprecision oncologybiomarker discoveryclinical decision supportmedical imaging AItumor biopsy analysistherapy response predictionpathology softwaresolid cancerSaaS platformtumor staining kits

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MultivisionDx Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

MultivisionDx Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Pre SeedDec 3, 2025
GrantNov 1, 2022

MultivisionDx Investors

Notable investors and investment history

InvestorRounds
Helsinki University FundsPre Seed
Business FinlandGrant
AntlerPre Seed
Kaikarhenni OyPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 3, 2025

    $1.18M raised in Pre Seed round.

MultivisionDx Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

MultivisionDx Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MultivisionDx's valuation, stock price, and market status.

Firmographic Details

HeadquartersHelsinki
Employee Range4
Year Founded2025
Last FundingDec 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.